Sterling Capital Management LLC Sells 11,630 Shares of GE HealthCare Technologies Inc. $GEHC

Sterling Capital Management LLC trimmed its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 42.8% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 15,539 shares of the company’s stock after selling 11,630 shares during the period. Sterling Capital Management LLC’s holdings in GE HealthCare Technologies were worth $1,106,000 at the end of the most recent quarter.

Other hedge funds have also recently bought and sold shares of the company. Laurel Wealth Advisors LLC bought a new stake in shares of GE HealthCare Technologies during the 4th quarter worth approximately $26,000. Optima Capital LLC bought a new position in GE HealthCare Technologies in the fourth quarter valued at approximately $27,000. Godfrey Financial Associates Inc. bought a new position in GE HealthCare Technologies in the fourth quarter valued at approximately $27,000. Montag A & Associates Inc. raised its position in GE HealthCare Technologies by 105.4% during the fourth quarter. Montag A & Associates Inc. now owns 341 shares of the company’s stock valued at $28,000 after purchasing an additional 175 shares in the last quarter. Finally, Transamerica Financial Advisors LLC raised its position in GE HealthCare Technologies by 331.6% during the fourth quarter. Transamerica Financial Advisors LLC now owns 341 shares of the company’s stock valued at $28,000 after purchasing an additional 262 shares in the last quarter. 82.06% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on GEHC shares. Piper Sandler reduced their target price on GE HealthCare Technologies from $88.00 to $74.00 in a report on Thursday, April 30th. Evercore set a $80.00 price target on GE HealthCare Technologies in a report on Thursday, April 30th. BTIG Research dropped their price objective on GE HealthCare Technologies from $85.00 to $80.00 and set a “buy” rating for the company in a research report on Wednesday, April 29th. HSBC reduced their price objective on GE HealthCare Technologies from $100.00 to $90.00 in a research note on Thursday, April 30th. Finally, Barclays decreased their target price on GE HealthCare Technologies from $87.00 to $78.00 and set an “equal weight” rating on the stock in a research report on Thursday, April 30th. Ten research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $80.20.

Insider Buying and Selling

In other GE HealthCare Technologies news, CFO James Saccaro bought 3,310 shares of GE HealthCare Technologies stock in a transaction on Friday, May 1st. The shares were purchased at an average cost of $60.60 per share, with a total value of $200,586.00. Following the acquisition, the chief financial officer directly owned 87,471 shares of the company’s stock, valued at $5,300,742.60. The trade was a 3.93% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Rodney F. Hochman purchased 1,618 shares of the firm’s stock in a transaction on Tuesday, May 12th. The stock was acquired at an average price of $62.03 per share, with a total value of $100,364.54. Following the completion of the transaction, the director owned 1,618 shares in the company, valued at approximately $100,364.54. This trade represents a ? increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have acquired a total of 21,847 shares of company stock valued at $1,361,355 over the last three months. Insiders own 0.36% of the company’s stock.

GE HealthCare Technologies Price Performance

Shares of GEHC opened at $64.01 on Wednesday. GE HealthCare Technologies Inc. has a 12-month low of $58.75 and a 12-month high of $89.77. The business has a 50-day simple moving average of $64.14 and a two-hundred day simple moving average of $73.62. The company has a quick ratio of 0.95, a current ratio of 1.22 and a debt-to-equity ratio of 0.95. The stock has a market cap of $29.12 billion, a PE ratio of 15.31, a PEG ratio of 1.77 and a beta of 0.74.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Wednesday, April 29th. The company reported $0.99 EPS for the quarter, missing the consensus estimate of $1.07 by ($0.08). GE HealthCare Technologies had a net margin of 9.10% and a return on equity of 20.46%. The firm had revenue of $5.13 billion during the quarter, compared to the consensus estimate of $5.04 billion. During the same quarter in the prior year, the business posted $1.01 earnings per share. GE HealthCare Technologies’s revenue for the quarter was up 7.4% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. Analysts anticipate that GE HealthCare Technologies Inc. will post 4.89 earnings per share for the current fiscal year.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.